نتائج البحث - Deborah A Hepler

  • يعرض 1 - 2 نتائج من 2
تنقيح النتائج
  1. 1
    Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease

    Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease حسب Oliver A. Cornely, Michael Robertson, Shariq Haider, Andrew Grigg, Michelle Geddes, Mickaël Aoun, Werner Heinz, Issam Raad, Urs Schanz, Ralf G. Meyer, Sarah P. Hammond, Kathleen M. Mullane, Helmut Ostermann, Andrew J. Ullmann, Stefan Zimmerli, Marlou L. P. S. van Iersel, Deborah A Hepler, Hetty Waskin, Nicholas A. Kartsonis, Johan Maertens

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Errata/Corrigenda
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Empiric vs Preemptive Antifungal Strategy in High-Risk Neutropenic Patients on Fluconazole Prophylaxis: A Randomized Trial of the European Organization for Research and Treatment of Cancer

    Empiric vs Preemptive Antifungal Strategy in High-Risk Neutropenic Patients on Fluconazole Prophylaxis: A Randomized Trial of the European Organization for Research and Treatment o... حسب Johan Maertens, Tom Lodewyck, J. Peter Donnelly, Sylvain Chantepie, Christine Robin, Nicole M. A. Blijlevens, Pascal Turlure, Dominik Selleslag, Frédéric Baron, Mickaël Aoun, Werner Heinz, Hartmut Bertz, Zdeněk Ráčil, Bernard E. Van Beers, Ľuboš Drgoňa, Valérie Coiteux, Cristina Castilla Llorente, Cornelia Schaefer‐Prokop, Marianne Paesmans, Lieveke Ameye, Liv Meert, Kin Jip Cheung, Deborah A Hepler, Jürgen Loeffler, Rosemary A. Barnes, Oscar Marchetti, Paul E. Verweij, Fréderic Lamoth, Pierre‐Yves Bochud, Michaël Schwarzinger, Catherine Cordonnier

    منشور في 2022
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: